Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Abstract

The tolerability of the combined checkpoint blockade in UM may possibly be better than in trials on cutaneous melanoma. This study implies that combined checkpoint blockade represents the hitherto most effective treatment option available for metastatic UM available outside of clinical trials.